SecBot SecBot
8-K ·Filed Jun 30, 2026

IRON

Disc Medicine, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago SEC0001193125-26-290542
8-K material event: Items 1.01
Actionable Insight • Neutral

Monitor the company's cash burn rate and upcoming pipeline catalysts (e.g., data readouts for bitopertin or DISC-0974) as the extended loan runway provides capital into 2028. The $30M draw signals active capital deployment, likely funding ongoing clinical trials. No pricing of Tranches 2/3 was disclosed, so the total potential debt is capped at an unknown amount.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$74.95
T+0 close · Jun 30, 2026 · via day close
Latest settled
−11.35%
T+60 · $66.44
Vs SPY
−14.23%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 1 $74.95entry
  2. T+1 · 5mo ago +1.75%α +1.88% · $76.26
  3. T+5 · 4mo ago +6.42%α +6.16% · $79.76
  4. T+20 · 4mo ago −1.71%α +0.48% · $73.67
  5. T+60 · 8w ago −11.35%α −14.23% · $66.44
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Disc Medicine amended its existing loan agreement with Hercules Capital, drawing $30M from Tranche 1-B and restructuring the remaining $50M Tranche 1-C into two $25M tranches. The amendment also extends draw periods for Tranches 2 and 3 to late 2027/2028 and defers the minimum cash covenant test to July 2028, providing extended financial flexibility for a pre-revenue biotech.

Key Financial Metrics

Deal Type
credit_facility

Key Facts

  • Disc Medicine drew $30M under Tranche 1-B of the Hercules Capital loan agreement.
  • The existing $50M Tranche 1-C was split into a $25M tranche available through March 31, 2027, and a $25M Tranche 1-D available through April 30, 2027.
  • Draw periods for Tranche 2 and Tranche 3 advances were extended to December 15, 2027 and June 30, 2028, respectively.
  • Minimum cash covenant initial testing date was deferred to July 1, 2028.
  • No financial data (revenue, earnings, cash balance) was reported in the filing; figures are not available for analysis.

Financial Impact

Drew $30M of existing debt capacity; total available future draws up to $75M across three tranches ($25M Tranche 1-C, $25M Tranche 1-D, plus Tranches 2 and 3 of undisclosed size). No revenue or earnings data in filing.

debtcash runwaycovenant flexibility

Risk Factors

  • Increased debt burden from the $30M draw and potential future draws; interest and covenants apply.
  • No product revenue; company remains pre-commercial with dependency on clinical-stage pipeline success.
  • Additional draws or amendments could dilute equity if debt converts or forces equity-linked financing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-290542
Document: 0001193125-26-290542-index-headers.html0001193125-26-290542
Document: 0001193125-26-290542-index.html0001193125-26-290542
Document: 0001193125-26-290542.txt0001193125-26-290542

Track record

43 reports on IRON

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +20.07% at T+20 after the Sep 3, 2026 report. 11 of 16 went positive at some point.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $87.08 Now $76.59 −12.05% settles Dec 10
  2. Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $78.91 Now $76.59 +2.94% settles Dec 7
  3. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  4. Nov 5, 202611d ago Press Release Bullish 7/10 Entry $78.47 Now $76.59 −2.40% settles Dec 4
  5. Nov 4, 202612d ago Press Release Neutral 3/10 Entry $83.28 Now $76.59 −8.03% settles Dec 3
  6. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $81.16 Now $76.59 −5.63% settles Dec 2
  7. Oct 26, 202621d ago SC 13D/A Neutral 3/10 Entry $79.90 Now $76.59 −4.14% settles Nov 24
  8. Oct 22, 202625d ago 8-K Bearish 6/10 Entry $74.51 Now $76.59 −2.79% settles Nov 20
  9. Oct 21, 202626d ago 424B5 Bearish 6/10 Entry $75.03 Now $76.59 −2.08% settles Nov 19
  10. Oct 21, 202626d ago 144 Neutral 2/10 Entry $75.03 Now $76.59 +2.08% settles Nov 19
Showing 10 of 43

US Market Status

Market Closed · Opens in 9h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026